Ligand validation:4MYX

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 4MYX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4MYX_IMP_B_500	65%	31%	0.16	0.964	1.45	1.28	2	3	2	0	100%	1
4MYX_IMP_A_501	64%	29%	0.15	0.949	1.55	1.3	2	4	1	0	100%	1
4MYX_IMP_G_501	62%	31%	0.161	0.954	1.47	1.29	2	4	1	0	100%	1
4MYX_IMP_C_502	61%	31%	0.17	0.959	1.48	1.28	2	4	1	0	100%	1
4MYX_IMP_H_504	54%	31%	0.179	0.946	1.47	1.3	2	4	1	0	100%	1
4MYX_IMP_F_501	49%	31%	0.195	0.943	1.47	1.28	2	4	1	0	100%	1
4MYX_IMP_E_501	45%	31%	0.187	0.917	1.47	1.27	2	4	0	0	100%	1
4MYX_IMP_D_504	41%	32%	0.236	0.951	1.46	1.26	2	4	1	0	100%	1
4MYA_IMP_A_500	97%	32%	0.069	0.986	1.43	1.27	2	2	1	0	100%	1
4MY8_IMP_B_501	89%	31%	0.093	0.973	1.44	1.33	2	4	1	0	100%	1
5UUV_IMP_B_501	83%	30%	0.112	0.97	1.49	1.3	2	4	2	0	100%	1
4MY1_IMP_B_500	82%	30%	0.12	0.976	1.44	1.37	3	3	1	0	100%	1
4QM1_IMP_D_500	80%	32%	0.125	0.976	1.46	1.23	2	4	4	0	100%	1
9AUV_IMP_E_801	100%	61%	0.028	0.992	0.78	0.7	-	-	0	0	100%	1
8QWA_IMP_A_501	100%	47%	0.038	0.987	1.01	1.04	3	3	0	0	100%	1
9DC8_IMP_A_801	100%	57%	0.041	0.985	0.82	0.83	-	-	0	0	100%	1
9DC9_IMP_A_801	99%	63%	0.044	0.983	0.66	0.77	-	-	1	0	100%	1
9AV3_IMP_A_801	99%	53%	0.043	0.98	0.94	0.88	1	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.